Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Ph.D., Southern Methodist University 1969
• 

  Previous Appointments & Affiliations

  • Professor of Biostatistics and Bioinformatics, Biostatistics & Bioinformatics, Basic Science Departments 2000 - 2015
  • Professor of Biostatistics in Community and Family Medicine with tenure, Family Medicine and Community Health, Clinical Science Departments 1988 - 2000
• Recognition
• 

  Awards & Honors

  • Fellow of the Society for Clinical Trials. Society for Clinical Trials. 2010
  • ASA Fellow. American Statistical Association. 1988
• Research
• 

  Selected Grants

  • Duke CTSA (TL1) awarded by National Institutes of Health 2018 - 2023
  • Translational meta-analysis for elderly lung cancer patients awarded by National Institutes of Health 2013 - 2016
  • CTSA UL awarded by National Institutes of Health 2006 - 2012
  • Cancer and Leukemia Group B Statistical Center awarded by National Institutes of Health 1982 - 2010
  • Prostate Cancer: Impact of Fat & Flaxseed Modified Diets awarded by National Institutes of Health 2002 - 2007
  • NCI Lung Signatures Study awarded by National Cancer Institute 2005 - 2006
  • GCRC CAP awarded by National Institutes of Health 2000 - 2005
  • Therapy of Temodar plus O6-Benzulguanine in Malignant Glioma awarded by National Institutes of Health 2003 - 2005
  • ZD1839 Therapy of Glioblastoma Multiforme awarded by National Institutes of Health 2001 - 2003
  • Hyperthermia And Perfusion Effects In Cancer Therapy awarded by National Institutes of Health 1987 - 1999
  • Cancer Center Core Support Grant awarded by National Institutes of Health 1976 - 1998
  • Comprehensive Cancer Center Core Support Grant awarded by National Institutes of Health 1976 - 1998
  • Comprehensive Cancer Center Core Support Grant awarded by National Institutes of Health 1976 - 1998
  • Cancer Information Service awarded by National Institutes of Health 1998
  • Cancer And Leukemia Group B - Statistical Center awarded by National Institutes of Health 1994 - 1998
  • Cancer And Leukemia Group B (Calgb) Statistical Center awarded by National Institutes of Health 1993 - 1998
  • Cancer & Leukemia Group B awarded by National Institutes of Health 1982 - 1998
  • Cancer And Leukemia Group B Statistical Center awarded by National Institutes of Health 1982 - 1998
  • Cancer And Leukemia Group B Statistical Center awarded by National Institutes of Health 1982 - 1998
  • Azacytidine In Myelodysplastic Syndromes Phase Iii Trial awarded by Food and Drug Administration 1995 - 1997
  • Hyperthermia And Perfusion Effects In Cancer Therapy awarded by National Institutes of Health 1993 - 1995
  • Cancer Information Service awarded by National Institutes of Health 1993 - 1994
  • Comprehensive Cancer Center Core Support Grant awarded by National Institutes of Health 1992 - 1993
  • Cancer & Leukemia Group B Statistical Center(Supp #12?) awarded by National Institutes of Health 1992 - 1993
  • Cancer And Leukemia Group B Statistical Center awarded by National Institutes of Health 1992 - 1993
  • Statistical Cancer Information Service awarded by National Institutes of Health 1990 - 1993
  • Cancer Information Service awarded by National Institutes of Health 1992
  • Calgb Statistical awarded by National Institutes of Health 1991 - 1992
  • Calgb Statistical Office awarded by National Institutes of Health 1991 - 1992
• Publications & Artistic Works
• 

  Selected Publications

  • Books

    • Jung, S. H. Design and analysis of phase II cancer clinical trials, 2016. https://doi.org/10.1201/9781315371566.
       Full Text

  • Academic Articles

    • Xia, Fang, Stephen L. George, Jing Ning, Liang Li, and Xuelin Huang. “A Signature Enrichment Design with Bayesian Adaptive Randomization.” Journal of Applied Statistics 48, no. 6 (January 2021): 1091–1110. https://doi.org/10.1080/02664763.2020.1757048.
       Full Text
    • Wang, Ting, Xiaofei Wang, Stephen L. George, and Haibo Zhou. “Design and analysis of biomarker-integrated clinical trials with adaptive threshold detection and flexible patient enrichment.” J Biopharm Stat 30, no. 6 (November 1, 2020): 1060–76. https://doi.org/10.1080/10543406.2020.1832110.
       Full Text  Link to Item
    • Wang, Xiaofei, Fangfang Bai, Herbert Pang, and Stephen L. George. “Bias-adjusted Kaplan-Meier survival curves for marginal treatment effect in observational studies.” J Biopharm Stat 29, no. 4 (2019): 592–605. https://doi.org/10.1080/10543406.2019.1633659.
       Full Text  Link to Item
    • Wang, Ting, Xiaofei Wang, Haibo Zhou, Jianwen Cai, and Stephen L. George. “Auxiliary variable-enriched biomarker-stratified design.” Stat Med 37, no. 30 (December 30, 2018): 4610–35. https://doi.org/10.1002/sim.7938.
       Full Text  Link to Item
    • Wang, Xiaofei, Jingzhu Zhou, Ting Wang, and Stephen L. George. “On Enrichment Strategies for Biomarker Stratified Clinical Trials.” J Biopharm Stat 28, no. 2 (2018): 292–308. https://doi.org/10.1080/10543406.2017.1379532.
       Full Text  Open Access Copy  Link to Item
    • Wang, Xiaofei, Xiaoyi Wang, Lydia Hodgson, Stephen L. George, Daniel J. Sargent, Nate R. Foster, Apar Kishor Ganti, et al. “Validation of Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials.” The Oncologist 22, no. 2 (February 10, 2017): 189–98. https://doi.org/10.1634/theoncologist.2016-0121.
       Full Text
    • George, Stephen L. “Prevalence of data fraud.” Int J Clin Oncol 21, no. 6 (December 2016): 1197. https://doi.org/10.1007/s10147-016-0991-z.
       Full Text  Link to Item
    • Zhu, Zhaoyin, Xiaofei Wang, Paramita Saha-Chaudhuri, Andrzej S. Kosinski, and Stephen L. George. “Time-dependent classification accuracy curve under marker-dependent sampling.” Biom J 58, no. 4 (July 2016): 974–92. https://doi.org/10.1002/bimj.201500171.
       Full Text  Link to Item
    • George, Stephen L. “Research misconduct and data fraud in clinical trials: prevalence and causal factors.” Int J Clin Oncol 21, no. 1 (February 2016): 15–21. https://doi.org/10.1007/s10147-015-0887-3.
       Full Text  Link to Item
    • Castillo, Jorge J., Flora Mulkey, Susan Geyer, Jonathan E. Kolitz, William Blum, Bayard L. Powell, Stephen L. George, Richard A. Larson, and Richard M. Stone. “Relationship between obesity and clinical outcome in adults with acute myeloid leukemia: A pooled analysis from four CALGB (alliance) clinical trials.” Am J Hematol 91, no. 2 (February 2016): 199–204. https://doi.org/10.1002/ajh.24230.
       Full Text  Link to Item
    • Xia, Fang, Stephen L. George, and Xiaofei Wang. “A Multi-state Model for Designing Clinical Trials for Testing Overall Survival Allowing for Crossover after Progression.” Stat Biopharm Res 8, no. 1 (2016): 12–21. https://doi.org/10.1080/19466315.2015.1093539.
       Full Text  Link to Item
    • George, Stephen L., and Marc Buyse. “Data fraud in clinical trials.” Clin Investig (Lond) 5, no. 2 (2015): 161–73. https://doi.org/10.4155/cli.14.116.
       Full Text  Link to Item
    • Kolitz, Jonathan E., Stephen L. George, Don M. Benson, Kati Maharry, Guido Marcucci, Ravi Vij, Bayard L. Powell, et al. “Recombinant interleukin-2 in patients aged younger than 60 years with acute myeloid leukemia in first complete remission: results from Cancer and Leukemia Group B 19808.” Cancer 120, no. 7 (April 1, 2014): 1010–17. https://doi.org/10.1002/cncr.28516.
       Full Text  Link to Item
    • Wang, Xiaofei, Junling Ma, and Stephen L. George. “ROC curve estimation under test-result-dependent sampling.” Biostatistics 14, no. 1 (January 2013): 160–72. https://doi.org/10.1093/biostatistics/kxs020.
       Full Text  Link to Item
    • Dickersin, Kay, George Williams, and Stephen George. “Panel discussion 1.” Clin Trials 9, no. 6 (December 2012): 696–704. https://doi.org/10.1177/1740774512463179.
       Full Text  Link to Item
    • Pang, Herbert, Stephen L. George, Ken Hui, and Tiejun Tong. “Gene selection using iterative feature elimination random forests for survival outcomes.” Ieee/Acm Trans Comput Biol Bioinform 9, no. 5 (September 2012): 1422–31. https://doi.org/10.1109/TCBB.2012.63.
       Full Text  Open Access Copy  Link to Item
    • Wang, Xiaofei, Junling Ma, Stephen George, and Haibo Zhou. “Estimation of AUC or Partial AUC under Test-Result-Dependent Sampling.” Stat Biopharm Res 4, no. 4 (January 1, 2012): 313–23. https://doi.org/10.1080/19466315.2012.692514.
       Full Text  Link to Item
    • Farag, Sherif S., Kati Maharry, Mei-Jie Zhang, Waleska S. Pérez, Stephen L. George, Krzysztof Mrózek, John DiPersio, et al. “Comparison of reduced-intensity hematopoietic cell transplantation with chemotherapy in patients age 60-70 years with acute myelogenous leukemia in first remission.” Biol Blood Marrow Transplant 17, no. 12 (December 2011): 1796–1803. https://doi.org/10.1016/j.bbmt.2011.06.005.
       Full Text  Link to Item
    • Buyse, Marc, Pierre Squifflet, Beverly J. Lange, Todd A. Alonzo, Richard A. Larson, Jonathan E. Kolitz, Stephen L. George, et al. “Individual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemia.” Blood 117, no. 26 (June 30, 2011): 7007–13. https://doi.org/10.1182/blood-2011-02-337725.
       Full Text  Link to Item
    • Michiels, Stefan, Richard F. Potthoff, and Stephen L. George. “Multiple testing of treatment-effect-modifying biomarkers in a randomized clinical trial with a survival endpoint.” Stat Med 30, no. 13 (June 15, 2011): 1502–18. https://doi.org/10.1002/sim.4022.
       Full Text  Link to Item
    • Sohn, Insuk, Kouros Owzar, Johan Lim, Stephen L. George, Stephanie Mackey Cushman, and Sin-Ho Jung. “Multiple testing for gene sets from microarray experiments.” Bmc Bioinformatics 12 (May 26, 2011): 209. https://doi.org/10.1186/1471-2105-12-209.
       Full Text  Open Access Copy  Link to Item
    • Baer, M. R., S. L. George, B. L. Sanford, K. Mrózek, J. E. Kolitz, J. O. Moore, R. M. Stone, et al. “Escalation of daunorubicin and addition of etoposide in the ADE regimen in acute myeloid leukemia patients aged 60 years and older: Cancer and Leukemia Group B Study 9720.” Leukemia 25, no. 5 (May 2011): 800–807. https://doi.org/10.1038/leu.2011.9.
       Full Text  Link to Item
    • Sargent, Daniel J., and Stephen L. George. “Clinical trials data collection: when less is more.” J Clin Oncol 28, no. 34 (December 1, 2010): 5019–21. https://doi.org/10.1200/JCO.2010.31.7024.
       Full Text  Link to Item
    • Kolitz, Jonathan E., Stephen L. George, Guido Marcucci, Ravi Vij, Bayard L. Powell, Steven L. Allen, Daniel J. DeAngelo, et al. “P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808.” Blood 116, no. 9 (September 2, 2010): 1413–21. https://doi.org/10.1182/blood-2009-07-229492.
       Full Text  Link to Item
    • Sohn, Insuk, Kouros Owzar, Stephen L. George, Sujong Kim, and Sin-Ho Jung. “Robust test method for time-course microarray experiments.” Bmc Bioinformatics 11 (July 22, 2010): 391. https://doi.org/10.1186/1471-2105-11-391.
       Full Text  Open Access Copy  Link to Item
    • Shterev, Ivo D., Sin-Ho Jung, Stephen L. George, and Kouros Owzar. “permGPU: Using graphics processing units in RNA microarray association studies.” Bmc Bioinformatics 11 (June 16, 2010): 329. https://doi.org/10.1186/1471-2105-11-329.
       Full Text  Open Access Copy  Link to Item
    • Hales, J. W., and S. George. “How the doughnut hole affects prescription fulfillment decisions involving cardiovascular medications for medicare Part D enrollees.” Managed Care 19, no. 12 (January 1, 2010).
    • Sohn, Insuk, Kouros Owzar, Stephen L. George, Sujong Kim, and Sin-Ho Jung. “A permutation-based multiple testing method for time-course microarray experiments.” Bmc Bioinformatics 10 (October 15, 2009): 336. https://doi.org/10.1186/1471-2105-10-336.
       Full Text  Link to Item
    • Potthoff, Richard F., and Stephen L. George. “Flexible Phase I Clinical Trials: Allowing for Nonbinary Toxicity Response and Removal of Other Common Limitations.” Stat Biopharm Res 1, no. 3 (August 1, 2009): 213–28. https://doi.org/10.1198/sbr.2009.0014.
       Full Text  Link to Item
    • Jung, Sin-Ho, Insuk Sohn, Stephen L. George, Liping Feng, and Phyllis C. Leppert. “Sample size calculation for microarray experiments with blocked one-way design.” Bmc Bioinformatics 10 (May 28, 2009): 164. https://doi.org/10.1186/1471-2105-10-164.
       Full Text  Link to Item
    • Jung, Sin-Ho, and Stephen L. George. “Between-arm comparisons in randomized Phase II trials.” J Biopharm Stat 19, no. 3 (2009): 456–68. https://doi.org/10.1080/10543400902802391.
       Full Text  Link to Item
    • Demark-Wahnefried, Wendy, Thomas J. Polascik, Stephen L. George, Boyd R. Switzer, John F. Madden, Mack T. Ruffin, Denise C. Snyder, et al. “Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery.” Cancer Epidemiol Biomarkers Prev 17, no. 12 (December 2008): 3577–87. https://doi.org/10.1158/1055-9965.EPI-08-0008.
       Full Text  Link to Item
    • Baer, Maria R., Stephen L. George, Michael A. Caligiuri, Ben L. Sanford, Sandra M. Bothun, Krzysztof Mrózek, Jonathan E. Kolitz, et al. “Low-dose interleukin-2 immunotherapy does not improve outcome of patients age 60 years and older with acute myeloid leukemia in first complete remission: Cancer and Leukemia Group B Study 9720.” J Clin Oncol 26, no. 30 (October 20, 2008): 4934–39. https://doi.org/10.1200/JCO.2008.17.0472.
       Full Text  Link to Item
    • George, Stephen L. “Statistical issues in translational cancer research.” Clin Cancer Res 14, no. 19 (October 1, 2008): 5954–58. https://doi.org/10.1158/1078-0432.CCR-07-4537.
       Full Text  Link to Item
    • Green, Mark R., Stephen L. George, Richard L. Schilsky, and Richard L. Cancer and Leukemia Group B. “Tomorrow's cancer treatments today: the first 50 years of the Cancer and Leukemia Group B.” Semin Oncol 35, no. 5 (October 2008): 470–83. https://doi.org/10.1053/j.seminoncol.2008.07.002.
       Full Text  Link to Item
    • Owzar, Kouros, William T. Barry, Sin-Ho Jung, Insuk Sohn, and Stephen L. George. “Statistical challenges in preprocessing in microarray experiments in cancer.” Clin Cancer Res 14, no. 19 (October 1, 2008): 5959–66. https://doi.org/10.1158/1078-0432.CCR-07-4532.
       Full Text  Link to Item
    • Baer, M. R., J. E. Kolitz, S. L. George, M. A. Caligiuri, and R. A. Larson. “Cancer and Leukemia Group B Studies of Recombinant Interleukin-2 Maintenance Therapy in Acute Myeloid Leukemia.” Annals of Hematology 87 (February 2008): S28–30.
       Link to Item
    • Baer, M. R., J. E. Kolitz, S. L. George, M. A. Caligiuri, and R. A. Larson. “Cancer and leukemia group B studies of recombinant interleukin-2 maintenance therapy in acute myeloid leukemia.” Annals of Hematology 87 (February 1, 2008): S28–30.
       Link to Item
    • Demark-Wahnefried, Wendy, Stephen L. George, Boyd R. Switzer, Denise C. Snyder, John F. Madden, Thomas J. Polascik, Mack T. Ruffin, and Robin T. Vollmer. “Overcoming challenges in designing and implementing a phase II randomized controlled trial using a presurgical model to test a dietary intervention in prostate cancer.” Clin Trials 5, no. 3 (2008): 262–72. https://doi.org/10.1177/1740774508091676.
       Full Text  Link to Item
    • Freidlin, Boris, Edward L. Korn, Stephen L. George, and Robert Gray. “Randomized clinical trial design for assessing noninferiority when superiority is expected.” J Clin Oncol 25, no. 31 (November 1, 2007): 5019–23. https://doi.org/10.1200/JCO.2007.11.8711.
       Full Text  Link to Item
    • Schiffer, C. A., and S. L. George. “Haematologic Cancers: Challenges in Developing New Therapeutic Approaches,” May 17, 2007, 167–75. https://doi.org/10.1002/9780470010167.ch12.
       Full Text
    • George, Stephen L. “Response rate as an endpoint in clinical trials.” J Natl Cancer Inst 99, no. 2 (January 17, 2007): 98–99. https://doi.org/10.1093/jnci/djk024.
       Full Text  Link to Item
    • George, S. L., and M. R. Green. “Controversies in the early reporting of a clinical trial in early breast cancer,” December 1, 2006, 346–59. https://doi.org/10.1007/0-387-30107-0_34.
       Full Text
    • Jung, S. H., K. Owzar, S. L. George, and T. Lee. “Rejoinder.” Journal of Biopharmaceutical Statistics 16, no. 6 (December 1, 2006): 781–83. https://doi.org/10.1080/10543400600954452.
       Full Text
    • Dilts, David M., Alan B. Sandler, Matthew Baker, Steven K. Cheng, Stephen L. George, Kathleen S. Karas, Stephen McGuire, et al. “Processes to activate phase III clinical trials in a Cooperative Oncology Group: the Case of Cancer and Leukemia Group B.” J Clin Oncol 24, no. 28 (October 1, 2006): 4553–57. https://doi.org/10.1200/JCO.2006.06.7819.
       Full Text  Link to Item
    • Aswathy, S., S. Sumithra, L. S. Valsala, S. Sandheep, V. Lohidas, P. Shobha, S. George, P. Francis, N. S. Rajeev, and A. J. Johnson. “Self reported morbidity and awareness regarding common cancers in elderly women.” J Commun Dis 38, no. 1 (March 2006): 106–11.
       Link to Item
    • Kolitz, J. E., S. L. George, M. R. Baer, E. J. Lee, C. D. Bloomfield, and R. A. Larson. “Cancer and leukemia group B (CALGB) multidrug resistance modulation trials in untreated acute myeloid leukemia.” Annals of Hematology 85 (February 1, 2006): 78–79.
       Link to Item
    • Jung, Sin-Ho, Kouros Owzar, Stephen L. George, and Taiyeong Lee. “P-value calculation for multistage phase II cancer clinical trials.” J Biopharm Stat 16, no. 6 (2006): 765–75. https://doi.org/10.1080/10543400600825645.
       Full Text  Link to Item
    • Jung, Sin-Ho, Kouros Owzar, and Stephen L. George. “A multiple testing procedure to associate gene expression levels with survival.” Stat Med 24, no. 20 (October 30, 2005): 3077–88. https://doi.org/10.1002/sim.2179.
       Full Text  Link to Item
    • Lamont, Elizabeth B., James E. Herndon, Jane C. Weeks, I Craig Henderson, Rogerio Lilenbaum, Richard L. Schilsky, and Nicholas A. Christakis. “Criterion validity of Medicare chemotherapy claims in Cancer and Leukemia Group B breast and lung cancer trial participants.” J Natl Cancer Inst 97, no. 14 (July 20, 2005): 1080–83. https://doi.org/10.1093/jnci/dji189.
       Full Text  Link to Item
    • Moore, Joseph O., Stephen L. George, Richard K. Dodge, Philip C. Amrein, Bayard L. Powell, Jonathan E. Kolitz, Maria R. Baer, et al. “Sequential multiagent chemotherapy is not superior to high-dose cytarabine alone as postremission intensification therapy for acute myeloid leukemia in adults under 60 years of age: Cancer and Leukemia Group B Study 9222.” Blood 105, no. 9 (May 1, 2005): 3420–27. https://doi.org/10.1182/blood-2004-08-2977.
       Full Text  Link to Item
    • Bang, Heejung, Sin-Ho Jung, and Stephen L. George. “Sample size calculation for simulation-based multiple-testing procedures.” J Biopharm Stat 15, no. 6 (2005): 957–67. https://doi.org/10.1080/10543400500265710.
       Full Text  Link to Item
    • Moser, Barry K., and Stephen L. George. “A general formulation for a one-sided group sequential design.” Clin Trials 2, no. 6 (2005): 519–28. https://doi.org/10.1191/1740774505cn120oa.
       Full Text  Link to Item
    • Kolitz, Jonathan E., Stephen L. George, Richard K. Dodge, David D. Hurd, Bayard L. Powell, Steven L. Allen, Enrique Velez-Garcia, et al. “Dose escalation studies of cytarabine, daunorubicin, and etoposide with and without multidrug resistance modulation with PSC-833 in untreated adults with acute myeloid leukemia younger than 60 years: final induction results of Cancer and Leukemia Group B Study 9621.” J Clin Oncol 22, no. 21 (November 1, 2004): 4290–4301. https://doi.org/10.1200/JCO.2004.11.106.
       Full Text  Link to Item
    • George, Stephen L., Boris Freidlin, and Edward L. Korn. “Strength of accumulating evidence and data monitoring committee decision making.” Stat Med 23, no. 17 (September 15, 2004): 2659–72. https://doi.org/10.1002/sim.1859.
       Full Text  Link to Item
    • Demmy, Todd L., Joyce M. Yasko, Deborah E. Collyar, Mira L. Katz, Carol L. Krasnov, Margaret J. Borwhat, Anne Battershell, and Stephen L. George. “Managing accrual in cooperative group clinical trials.” J Clin Oncol 22, no. 15 (August 1, 2004): 2997–3002. https://doi.org/10.1200/JCO.2004.10.073.
       Full Text  Link to Item
    • Halabi, Susan, Eric J. Small, Nicholas J. Vogelzang, Robert C. Barrier, Stephen L. George, and Timothy D. Gilligan. “Impact of race on survival in men with metastatic hormone-refractory prostate cancer.” Urology 64, no. 2 (August 2004): 212–17. https://doi.org/10.1016/j.urology.2004.04.014.
       Full Text
    • Joffe, S., D. P. Harrington, S. L. George, E. J. Emanuel, L. Budzinski, and J. C. Weeks. “Fulfillment of the uncertainty principle in cancer clinical trials.” J Clin Oncol 22, no. 14_suppl (July 15, 2004): 6003.
       Link to Item
    • Joffe, Steven, David P. Harrington, Stephen L. George, Ezekiel J. Emanuel, Lindsay A. Budzinski, and Jane C. Weeks. “Satisfaction of the uncertainty principle in cancer clinical trials: retrospective cohort analysis.” Bmj 328, no. 7454 (June 19, 2004): 1463. https://doi.org/10.1136/bmj.38118.685289.55.
       Full Text  Link to Item
    • Ellenberg, Susan S., and Stephen L. George. “Should statisticians reporting to data monitoring committees be independent of the trial sponsor and leadership?” Stat Med 23, no. 10 (May 30, 2004): 1503–5. https://doi.org/10.1002/sim.1784.
       Full Text  Link to Item
    • George, S., X. Z. Ruan, C. Navarrete, D. Turner, M. Reynard, P. Sweny, G. Hamilton, et al. “Renovascular disease is associated with low producer genotypes of the anti-inflammatory cytokine interleukin-10.” Tissue Antigens 63, no. 5 (May 2004): 470–75. https://doi.org/10.1111/j.0001-2815.2004.00183.x.
       Full Text  Link to Item
    • Jung, Sin-Ho, Taiyeong Lee, KyungMann Kim, and Stephen L. George. “Admissible two-stage designs for phase II cancer clinical trials.” Stat Med 23, no. 4 (February 28, 2004): 561–69. https://doi.org/10.1002/sim.1600.
       Full Text  Link to Item
    • Korn, Edward L., Boris Freidlin, and Stephen L. George. “Data monitoring and large apparent treatment effects.” Control Clin Trials 25, no. 1 (February 2004): 67–69. https://doi.org/10.1016/S0197-2456(03)00109-0.
       Full Text  Link to Item
    • Dickersin, Kay, Barry R. Davis, Dennis O. Dixon, Stephen L. George, Barbara S. Hawkinse, John Lachin, Peter Peduzzi, Stuart Pocock, and Stuart Society for Clinical Trials. “The Society for Clinical Trials supports United States legislation mandating trials registration. Position paper.” Clin Trials 1, no. 5 (2004): 417–20. https://doi.org/10.1191/1740774504cn039oa.
       Full Text  Link to Item
    • Halperin, Edward C., Marie L. Miranda, Dorothy M. Watson, Stephen L. George, and Matthew Stanberry. “Medulloblastoma and birth date: evaluation of 3 U.S. datasets.” Arch Environ Health 59, no. 1 (January 2004): 26–30. https://doi.org/10.3200/AEOH.59.1.26-30.
       Full Text  Link to Item
    • George, S., F. Yunus, D. Case, B. B. Yang, J. Hackett, J. E. Shogan, L. A. Meza, T. A. Neumann, and B. C. Liang. “Fixed-dose pegfilgrastim is safe and allows neutrophil recovery in patients with non-Hodgkin's lymphoma.” Leuk Lymphoma 44, no. 10 (October 2003): 1691–96. https://doi.org/10.1080/1042819031000063462.
       Full Text  Link to Item
    • George, Stephen L. “Selection bias, phase II trials, and the FDA accelerated approval process.” J Natl Cancer Inst 95, no. 18 (September 17, 2003): 1351–52. https://doi.org/10.1093/jnci/djg070.
       Full Text  Link to Item
    • George, S., A. Johansen, M. A. Soos, H. Mortensen, S. Gammeltoft, V. Saudek, K. Siddle, L. Hansen, and S. O’Rahilly. “Deletion of V335 from the L2 domain of the insulin receptor results in a conformationally abnormal receptor that is unable to bind insulin and causes Donohue's syndrome in a human subject.” Endocrinology 144, no. 2 (February 2003): 631–37. https://doi.org/10.1210/en.2002-220815.
       Full Text  Link to Item
    • George, Stephen, and Robin A. Braithwaite. “Use of on-site testing for drugs of abuse.” Clin Chem 48, no. 10 (October 2002): 1639–46.
       Link to Item
    • Gamel, John W., Stephen L. George, Michael J. Edwards, and Hilliard F. Seigler. “The long-term clinical course of patients with cutaneous melanoma.” Cancer 95, no. 6 (September 15, 2002): 1286–93. https://doi.org/10.1002/cncr.10813.
       Full Text  Link to Item
    • Farag, Sherif S., Stephen L. George, Edward J. Lee, Maria Baer, Richard K. Dodge, Brian Becknell, Todd A. Fehniger, et al. “Postremission therapy with low-dose interleukin 2 with or without intermediate pulse dose interleukin 2 therapy is well tolerated in elderly patients with acute myeloid leukemia: Cancer and Leukemia Group B study 9420.” Clin Cancer Res 8, no. 9 (September 2002): 2812–19.
       Link to Item
    • Payne, S., F. Sheldon, N. Jarrett, S. Large, P. Smith, C. L. Davis, P. Turner, and S. George. “Differences in understanding of specialist palliative care amongst service providers and commissioners in South London.” Palliat Med 16, no. 5 (September 2002): 395–402. https://doi.org/10.1191/0269216302pm572oa.
       Full Text  Link to Item
    • Baer, Maria R., Stephen L. George, Richard K. Dodge, Kieran L. O’Loughlin, Hans Minderman, Michael A. Caligiuri, John Anastasi, et al. “Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720.” Blood 100, no. 4 (August 15, 2002): 1224–32.
       Link to Item
    • Erban, J. K., S. George, E. B. Berkman, K. A. Sprague, P. Coury, R. Wiseman, L. Zaslavsky, D. E. Wazer, K. B. Miller, and D. P. Schenkein. “Effect of filgrastim priming dose on peripheral blood progenitor cell yield, engraftment, and survival in women undergoing high dose chemotherapy for breast cancer.” Breast Cancer Research and Treatment 69, no. 3 (December 1, 2001): 282.
    • Whitman, S. P., K. J. Archer, L. Feng, C. Baldus, B. Becknell, B. D. Carlson, A. J. Carroll, et al. “The FLT3 internal tandem duplication in normal karyotype adult de novo AML lacking the wildtype FLT3 gene predicts poor prognosis: A Cancer and Leukemia Group B study.” Clinical Cancer Research 7, no. 11 (November 1, 2001): 3767S-3767S.
       Link to Item
    • Whitman, S. P., K. J. Archer, L. Feng, C. Baldus, B. Becknell, B. D. Carlson, A. J. Carroll, et al. “Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study.” Cancer Res 61, no. 19 (October 1, 2001): 7233–39.
       Link to Item
    • Stone, R. M., D. T. Berg, S. L. George, R. K. Dodge, P. A. Paciucci, P. P. Schulman, E. J. Lee, et al. “Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine.” Blood 98, no. 3 (August 1, 2001): 548–53. https://doi.org/10.1182/blood.v98.3.548.
       Full Text  Link to Item
    • Lachenbruch, P., G. Murray, J. Ranstam, and B. Scherrer. “Knowledge of fraud among biostatisticians.” Control Clin Trials 22, no. 3 (June 2001): 263–64. https://doi.org/10.1016/s0197-2456(01)00114-3.
       Full Text  Link to Item
    • Brockington, I. F., J. Oates, S. George, D. Turner, P. Vostanis, M. Sullivan, C. Loh, and C. Murdoch. “A screening questionnaire for mother-infant bonding disorders.” Archives of Women’S Mental Health 3, no. 4 (April 17, 2001): 133–40. https://doi.org/10.1007/s007370170010.
       Full Text
    • Halperin, E. C., D. M. Watson, and S. L. George. “Duration of symptoms prior to diagnosis is related inversely to presenting disease stage in children with medulloblastoma.” Cancer 91, no. 8 (April 15, 2001): 1444–50. https://doi.org/10.1002/1097-0142(20010415)91:8<1444::aid-cncr1151>3.0.co;2-u.
       Full Text  Link to Item
    • George, S., D. Turner, M. Reynard, C. Navarrete, I. Rizvi, O. N. Fernando, S. H. Powis, J. F. Moorhead, and Z. Varghese. “Significance of cytokine gene polymorphism in renal transplantation.” Transplant Proc 33, no. 1–2 (February 2001): 483–84. https://doi.org/10.1016/s0041-1345(00)02103-5.
       Full Text  Link to Item
    • Potthoff, R. F., B. L. Peterson, and S. L. George. “Detecting treatment-by-centre interaction in multi-centre clinical trials.” Stat Med 20, no. 2 (January 30, 2001): 193–213. https://doi.org/10.1002/1097-0258(20010130)20:2<193::aid-sim651>3.0.co;2-#.
       Full Text  Link to Item
    • Umiel, T., S. George, P. Beitsch, and T. J. Moss. “Detection of micrometastatic clonogenic growth in bone marrow of early stage breast cancer patients presenting with or without lymph node involvement.” Breast Cancer Research and Treatment 69, no. 3 (January 1, 2001): 258.
    • Ranstam, J., M. Buyse, S. L. George, S. Evans, N. L. Geller, B. Scherrer, E. Lesaffre, et al. “Fraud in medical research: an international survey of biostatisticians. ISCB Subcommittee on Fraud.” Control Clin Trials 21, no. 5 (October 2000): 415–27. https://doi.org/10.1016/s0197-2456(00)00069-6.
       Full Text  Link to Item
    • “Surgery for colorectal cancer in elderly patients: a systematic review. Colorectal Cancer Collaborative Group.” Lancet 356, no. 9234 (September 16, 2000): 968–74.
       Link to Item
    • Orzeck, E. A., and S. George. “Ovarian dysmetabolic syndrome.” Endocr Pract 6, no. 5 (September 2000): 410. https://doi.org/10.4158/EP.6.5.410.
       Full Text  Link to Item
    • George, S., L. Gill, and R. A. Braithwaite. “Simple high-performance liquid chromatographic method to monitor vigabatrin, and preliminary review of concentrations determined in epileptic patients.” Ann Clin Biochem 37 ( Pt 3) (May 2000): 338–42. https://doi.org/10.1258/0004563001899249.
       Full Text  Link to Item
    • Buyse, M., S. L. George, S. Evans, N. L. Geller, J. Ranstam, B. Scherrer, E. Lesaffre, et al. “The role of biostatistics in the prevention, detection and treatment of fraud in clinical trials.” Stat Med 18, no. 24 (December 30, 1999): 3435–51. https://doi.org/10.1002/(sici)1097-0258(19991230)18:24<3435::aid-sim365>3.0.co;2-o.
       Full Text  Link to Item
    • Freidlin, B., E. L. Korn, and S. L. George. “Data monitoring committees and interim monitoring guidelines.” Control Clin Trials 20, no. 5 (October 1999): 395–407. https://doi.org/10.1016/s0197-2456(99)00017-3.
       Full Text  Link to Item
    • Lee, E. J., S. L. George, M. Caligiuri, T. P. Szatrowski, B. L. Powell, S. Lemke, R. K. Dodge, R. Smith, M. Baer, and C. A. Schiffer. “Parallel phase I studies of daunorubicin given with cytarabine and etoposide with or without the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age or older with acute myeloid leukemia: results of cancer and leukemia group B study 9420.” J Clin Oncol 17, no. 9 (September 1999): 2831–39. https://doi.org/10.1200/JCO.1999.17.9.2831.
       Full Text  Link to Item
    • Thrall, D. E., S. M. Larue, B. E. Powers, R. L. Page, J. Johnson, S. L. George, J. N. Kornegay, et al. “Use of whole body hyperthermia as a method to heat inaccessible tumours uniformly: a phase III trial in canine brain masses.” Int J Hyperthermia 15, no. 5 (September 1999): 383–98. https://doi.org/10.1080/026567399285576.
       Full Text  Link to Item
    • Goodman, S. N., D. G. Altman, and S. L. George. “Statistical reviewing policies of medical journals: caveat lector?” J Gen Intern Med 13, no. 11 (November 1998): 753–56. https://doi.org/10.1046/j.1525-1497.1998.00227.x.
       Full Text  Link to Item
    • Knatterud, G. L., F. W. Rockhold, S. L. George, F. B. Barton, C. E. Davis, W. R. Fairweather, T. Honohan, R. Mowery, and R. O’Neill. “Guidelines for quality assurance in multicenter trials: a position paper.” Controlled Clinical Trials 19, no. 5 (October 1998): 477–93.
    • Larson, R. A., R. K. Dodge, C. A. Linker, R. M. Stone, B. L. Powell, E. J. Lee, P. Schulman, et al. “A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111.” Blood 92, no. 5 (September 1, 1998): 1556–64.
       Link to Item
    • Brizel, D. M., M. E. Albers, S. R. Fisher, R. L. Scher, W. J. Richtsmeier, V. Hars, S. L. George, A. T. Huang, and L. R. Prosnitz. “Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer.” N Engl J Med 338, no. 25 (June 18, 1998): 1798–1804. https://doi.org/10.1056/NEJM199806183382503.
       Full Text  Link to Item
    • Lee, E. J., S. L. George, P. C. Amrein, P. A. Paciucci, S. L. Allen, and C. A. Schiffer. “An evaluation of combinations of diaziquone, etoposide and mitoxantrone in the treatment of adults with relapsed or refractory acute myeloid leukemia: results of 8722, a randomized phase II study conducted by Cancer and Leukemia Group B.” Leukemia 12, no. 2 (February 1998): 139–43. https://doi.org/10.1038/sj.leu.2400905.
       Full Text  Link to Item
    • George, S., and R. A. Braithwaite. “The measurement of morphine in the hair of heroin abusers.” Ann Clin Biochem 34 ( Pt 4) (July 1997): 375–83. https://doi.org/10.1177/000456329703400407.
       Full Text  Link to Item
    • Voort, E. R. van der, P. van der Ley, J. van der Biezen, S. George, O. Tunnela, H. van Dijken, B. Kuipers, and J. Poolman. “Specificity of human bactericidal antibodies against PorA P1.7,16 induced with a hexavalent meningococcal outer membrane vesicle vaccine.” Infect Immun 64, no. 7 (July 1996): 2745–51. https://doi.org/10.1128/iai.64.7.2745-2751.1996.
       Full Text  Link to Item
    • George, S. L. “Reducing patient eligibility criteria in cancer clinical trials.” J Clin Oncol 14, no. 4 (April 1996): 1364–70. https://doi.org/10.1200/JCO.1996.14.4.1364.
       Full Text  Link to Item
    • George, S. “The approach of the british government to the 1996 intergovernmental conference of the european union.” Journal of European Public Policy 3, no. 1 (January 1, 1996): 45–62. https://doi.org/10.1080/13501769608407017.
       Full Text
    • George, S., A. J. Wood, and R. A. Braithwaite. “Routine therapeutic monitoring of lamotrigine in epileptic patients using a simple and rapid high performance liquid chromatographic technique.” Ann Clin Biochem 32 ( Pt 6) (November 1995): 584–88. https://doi.org/10.1177/000456329503200611.
       Full Text  Link to Item
    • Bennett, C. L., T. J. Smith, S. L. George, B. E. Hillner, S. Fleishman, and H. B. Niell. “Free-riding and the prisoner's dilemma: problems in funding economic analyses of phase III cancer clinical trials.” J Clin Oncol 13, no. 9 (September 1995): 2457–63. https://doi.org/10.1200/JCO.1995.13.9.2457.
       Full Text  Link to Item
    • Bennett, C. L., S. L. George, J. M. Vose, J. J. Nemunaitis, J. L. Armitage, J. O. Armitage, N. C. Gorin, and S. C. Gulati. “Granulocyte-macrophage colony-stimulating factor as adjunct therapy in relapsed lymphoid malignancy: implications for economic analyses of phase III clinical trials.” Stem Cells 13, no. 4 (July 1995): 414–20. https://doi.org/10.1002/stem.5530130412.
       Full Text  Link to Item
    • George, S. “Special events: are they worth the trouble?” Fund Raising Manage 26, no. 5 (July 1995): 22–24.
       Link to Item
    • Stone, R. M., D. T. Berg, S. L. George, R. K. Dodge, P. A. Paciucci, P. Schulman, E. J. Lee, J. O. Moore, B. L. Powell, and C. A. Schiffer. “Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B.” N Engl J Med 332, no. 25 (June 22, 1995): 1671–77. https://doi.org/10.1056/NEJM199506223322503.
       Full Text  Link to Item
    • Larson, R. A., R. K. Dodge, C. P. Burns, E. J. Lee, R. M. Stone, P. Schulman, D. Duggan, F. R. Davey, R. E. Sobol, and S. R. Frankel. “A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.” Blood 85, no. 8 (April 15, 1995): 2025–37.
       Link to Item
    • Larson, R. A., R. K. Dodge, C. P. Burns, E. J. Lee, R. M. Stone, P. Schulman, D. Duggan, et al. “A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: Cancer and leukemia group B study 8811.” Blood 85, no. 8 (April 15, 1995): 2025–37. https://doi.org/10.1182/blood.v85.8.2025.bloodjournal8582025.
       Full Text
    • Page, R. L., M. C. McEntee, P. L. Williams, S. L. George, G. S. Price, C. A. Novotney, M. L. Hauck, J. E. Riviere, M. W. Dewhirst, and D. E. Thrall. “Effect of whole body hyperthermia on carboplatin disposition and toxicity in dogs.” Int J Hyperthermia 10, no. 6 (November 1994): 807–16. https://doi.org/10.3109/02656739409012373.
       Full Text  Link to Item
    • George, S., and R. A. Braithwaite. “Drugs of abuse screening in the West Midlands: a 6 year retrospective survey of results.” Ann Clin Biochem 31 ( Pt 5) (September 1994): 473–78. https://doi.org/10.1177/000456329403100509.
       Full Text  Link to Item
    • George, S. L., C. Li, D. A. Berry, and M. R. Green. “Stopping a clinical trial early: frequentist and Bayesian approaches applied to a CALGB trial in non-small-cell lung cancer.” Stat Med 13, no. 13–14 (July 15, 1994): 1313–27. https://doi.org/10.1002/sim.4780131305.
       Full Text  Link to Item
    • Harrington, D., J. Crowley, S. L. George, T. Pajak, C. Redmond, and S. Wieand. “The case against independent monitoring committees.” Stat Med 13, no. 13–14 (July 15, 1994): 1411–14. https://doi.org/10.1002/sim.4780131316.
       Full Text  Link to Item
    • George, S., R. A. Braithwaite, and E. A. Hughes. “Digoxin measurements following plasma ultrafiltration in two patients with digoxin toxicity treated with specific Fab fragments.” Ann Clin Biochem 31 ( Pt 4) (July 1994): 380–82. https://doi.org/10.1177/000456329403100415.
       Full Text  Link to Item
    • George, S. L. “Statistical considerations and modeling of clinical utility of tumor markers.” Hematol Oncol Clin North Am 8, no. 3 (June 1994): 457–70.
       Link to Item
    • Neubauer, A., R. K. Dodge, S. L. George, F. R. Davey, R. T. Silver, C. A. Schiffer, R. J. Mayer, E. D. Ball, D. Wurster-Hill, and C. D. Bloomfield. “Prognostic importance of mutations in the ras proto-oncogenes in de novo acute myeloid leukemia.” Blood 83, no. 6 (March 15, 1994): 1603–11.
       Link to Item
    • George, S., D. Mathai, V. Balraj, M. K. Lalitha, and T. J. John. “An outbreak of anthrax meningoencephalitis.” Trans R Soc Trop Med Hyg 88, no. 2 (March 1994): 206–7. https://doi.org/10.1016/0035-9203(94)90298-4.
       Full Text  Link to Item
    • GRIEVE, A. P., S. J. POCOCK, K. ABRAMS, D. ASHBY, M. J. R. HEALY, C. JENNISON, J. A. LEWIS, et al. “BAYESIAN APPROACHES TO RANDOMIZED TRIALS - DISCUSSION.” Journal of the Royal Statistical Society Series a Statistics in Society 157 (January 1, 1994): 387–416.
       Link to Item
    • George, S. L. “Discussion of 'Sequential methods based on the boundaries approach for the clinical comparison of survival times'.” Statistics in Medicine 13, no. 13–14 (1994): 1369–70.
    • Peterson, B., and S. L. George. “Erratum: (Controlled Clinical Trials, Volume 14, Number 6, December 1993, page 511, 512, 515).” Controlled Clinical Trials 15, no. 4 (January 1, 1994): 326.
    • Peterson, B., and S. L. George. “Sample size requirements and length of study for testing interaction in a 2 x k factorial design when time-to-failure is the outcome [corrected].” Control Clin Trials 14, no. 6 (December 1993): 511–22. https://doi.org/10.1016/0197-2456(93)90031-8.
       Full Text  Link to Item
    • Ozer, H., S. L. George, C. A. Schiffer, K. Rao, P. N. Rao, D. H. Wurster-Hill, D. D. Arthur, et al. “Prolonged subcutaneous administration of recombinant alpha 2b interferon in patients with previously untreated Philadelphia chromosome-positive chronic-phase chronic myelogenous leukemia: effect on remission duration and survival: Cancer and Leukemia Group B study 8583.” Blood 82, no. 10 (November 15, 1993): 2975–84.
       Link to Item
    • Gamel, J. W., S. L. George, W. E. Stanley, and H. F. Seigler. “Skin melanoma. Cured fraction and survival time as functions of thickness, site, histologic type, age, and sex.” Cancer 72, no. 4 (August 15, 1993): 1219–23. https://doi.org/10.1002/1097-0142(19930815)72:4<1219::aid-cncr2820720414>3.0.co;2-0.
       Full Text  Link to Item
    • Page, R. L., M. C. McEntee, S. L. George, P. L. Williams, G. L. Heidner, C. A. Novotney, J. E. Riviere, M. W. Dewhirst, and D. E. Thrall. “Pharmacokinetic and phase I evaluation of carboplatin in dogs.” J Vet Intern Med 7, no. 4 (July 1993): 235–40. https://doi.org/10.1111/j.1939-1676.1993.tb01013.x.
       Full Text  Link to Item
    • Halperin, E. C., L. Gaspar, S. George, D. Darr, and S. Pinnell. “A double-blind, randomized, prospective trial to evaluate topical vitamin C solution for the prevention of radiation dermatitis. CNS Cancer Consortium.” Int J Radiat Oncol Biol Phys 26, no. 3 (June 15, 1993): 413–16. https://doi.org/10.1016/0360-3016(93)90958-x.
       Full Text  Link to Item
    • Withrow, S. J., D. E. Thrall, R. C. Straw, B. E. Powers, R. H. Wrigley, S. M. Larue, R. L. Page, D. C. Richardson, K. W. Bissonette, and C. W. Betts. “Intra-arterial cisplatin with or without radiation in limb-sparing for canine osteosarcoma.” Cancer 71, no. 8 (April 15, 1993): 2484–90. https://doi.org/10.1002/1097-0142(19930415)71:8<2484::aid-cncr2820710810>3.0.co;2-d.
       Full Text  Link to Item
    • Leopold, K. A., M. W. Dewhirst, T. V. Samulski, R. K. Dodge, S. L. George, J. L. Blivin, L. R. Prosnitz, and J. R. Oleson. “Cumulative minutes with T90 greater than Tempindex is predictive of response of superficial malignancies to hyperthermia and radiation.” Int J Radiat Oncol Biol Phys 25, no. 5 (April 2, 1993): 841–47. https://doi.org/10.1016/0360-3016(93)90314-l.
       Full Text  Link to Item
    • George, S. L. “A survey of monitoring practices in cancer clinical trials.” Stat Med 12, no. 5–6 (March 1993): 435–50. https://doi.org/10.1002/sim.4780120507.
       Full Text  Link to Item
    • Peter, J. V., O. C. Abraham, S. George, K. N. Brahmadathan, and D. Mathai. “Toxic strep syndrome.” J Assoc Physicians India 41, no. 3 (March 1993): 175–76.
       Link to Item
    • Oleson, J. R., T. V. Samulski, K. A. Leopold, S. T. Clegg, M. W. Dewhirst, R. K. Dodge, and S. L. George. “Sensitivity of hyperthermia trial outcomes to temperature and time: implications for thermal goals of treatment.” Int J Radiat Oncol Biol Phys 25, no. 2 (January 15, 1993): 289–97. https://doi.org/10.1016/0360-3016(93)90351-u.
       Full Text  Link to Item
    • George, S., S. Green, J. Crowley, S. Ellenberg, C. Meinert, L. Friedman, L. Brown, et al. “Discussion: Stephen George, a survey of monitoring practices in cancer clinical trials: Stephanie Green and John Crowley, data monitoring committees for Southwest Oncology Group clinical trials.” Statistics in Medicine 12, no. 5–6 (January 1, 1993): 457–59.
    • Halperin, E. C., J. Scott, and S. L. George. “Multiple authorship in two English-language journals in radiation oncology.” Acad Med 67, no. 12 (December 1992): 850–56. https://doi.org/10.1097/00001888-199212000-00012.
       Full Text  Link to Item
    • Page, R. L., D. E. Thrall, S. L. George, G. S. Price, G. L. Heidner, M. C. McEntee, C. A. Novotney, M. L. Hauck, and M. W. Dewhirst. “Quantitative estimation of the thermal dose-modifying factor for cis-diamminedichloroplatinum (CDDP) in tumour-bearing dogs.” Int J Hyperthermia 8, no. 6 (November 1992): 761–69. https://doi.org/10.3109/02656739209005024.
       Full Text  Link to Item
    • Crews, J. R., L. A. Maier, Y. H. Yu, S. Hester, K. O’Briant, D. S. Leslie, K. DeSombre, S. L. George, C. M. Boyer, and Y. Argon. “A combination of two immunotoxins exerts synergistic cytotoxic activity against human breast-cancer cell lines.” Int J Cancer 51, no. 5 (July 9, 1992): 772–79. https://doi.org/10.1002/ijc.2910510518.
       Full Text  Link to Item
    • Daly, L., J. Ferguson, G. P. Cram, V. Hars, S. L. George, K. S. McCarty, and R. C. Bast. “Comparison of a novel assay for breast cancer mucin to CA15-3 and carcinoembryonic antigen.” J Clin Oncol 10, no. 7 (July 1992): 1057–65. https://doi.org/10.1200/JCO.1992.10.7.1057.
       Full Text  Link to Item
    • O’Briant, K., N. Chrysson, V. Hunter, F. Tyson, M. Tanner, L. Daly, S. L. George, A. Berchuck, J. Soper, and W. Fowler. “Ha-ras polymorphisms in epithelial ovarian cancer.” Gynecol Oncol 45, no. 3 (June 1992): 299–302. https://doi.org/10.1016/0090-8258(92)90308-6.
       Full Text  Link to Item
    • Harpole, D. H., C. M. Johnson, W. G. Wolfe, S. L. George, and H. F. Seigler. “Analysis of 945 cases of pulmonary metastatic melanoma.” J Thorac Cardiovasc Surg 103, no. 4 (April 1992): 743–48.
       Link to Item
    • Tomberlin, J. K., E. C. Halperin, P. Kusin, K. Leopold, G. Bentel, S. George, M. Powers, and W. Wolfe. “Endobronchial interstitial Au-198 implantation in the treatment of recurrent bronchogenic carcinoma.” J Surg Oncol 49, no. 4 (April 1992): 213–19. https://doi.org/10.1002/jso.2930490403.
       Full Text  Link to Item
    • Fisher, S. R., H. F. Seigler, and S. L. George. “Therapeutic and prognostic considerations of head and neck melanoma.” Ann Plast Surg 28, no. 1 (January 1992): 78–80. https://doi.org/10.1097/00000637-199201000-00020.
       Full Text  Link to Item
    • Leopold, K. A., M. Dewhirst, T. Samulski, J. Harrelson, J. A. Tucker, S. L. George, R. K. Dodge, W. Grant, S. Clegg, and L. R. Prosnitz. “Relationships among tumor temperature, treatment time, and histopathological outcome using preoperative hyperthermia with radiation in soft tissue sarcomas.” Int J Radiat Oncol Biol Phys 22, no. 5 (1992): 989–98. https://doi.org/10.1016/0360-3016(92)90798-m.
       Full Text  Link to Item
    • Raju, A. Z., D. Mathai, J. P. Singh, A. Kaur, S. George, and B. M. Pulimood. “Candidal oesophagitis in Cushing's syndrome.” J Assoc Physicians India 39, no. 9 (September 1991): 719–21.
       Link to Item
    • Pui, C. H., R. K. Dodge, A. T. Look, S. L. George, G. K. Rivera, M. Abromowitch, J. Ochs, W. E. Evans, W. M. Crist, and J. V. Simone. “Risk of adverse events in children completing treatment for acute lymphoblastic leukemia: St. Jude Total Therapy studies VIII, IX, and X.” J Clin Oncol 9, no. 8 (August 1991): 1341–47. https://doi.org/10.1200/JCO.1991.9.8.1341.
       Full Text  Link to Item
    • Page, R. L., D. E. Thrall, M. W. Dewhirst, D. W. Macy, S. L. George, M. C. McEntee, G. L. Heidner, C. A. Novotney, S. A. Allen, and S. J. Withrow. “Phase I study of melphalan alone and melphalan plus whole body hyperthermia in dogs with malignant melanoma.” Int J Hyperthermia 7, no. 4 (July 1991): 559–66. https://doi.org/10.3109/02656739109034968.
       Full Text  Link to Item
    • Schwartzbaum, J. A., S. L. George, C. B. Pratt, and B. Davis. “An exploratory study of environmental and medical factors potentially related to childhood cancer.” Med Pediatr Oncol 19, no. 2 (1991): 115–21. https://doi.org/10.1002/mpo.2950190209.
       Full Text  Link to Item
    • Yu, Y. H., J. R. Crews, K. Cooper, S. Ramakrishnan, L. L. Houston, D. S. Leslie, S. L. George, Y. Lidor, C. M. Boyer, and D. B. Ring. “Use of immunotoxins in combination to inhibit clonogenic growth of human breast carcinoma cells.” Cancer Res 50, no. 11 (June 1, 1990): 3231–38.
       Link to Item
    • Pratt, C. B., J. E. Champion, I. D. Fleming, B. Rao, A. P. Kumar, W. E. Evans, A. A. Green, and S. George. “Adjuvant chemotherapy for osteosarcoma of the extremity. Long-term results of two consecutive prospective protocol studies.” Cancer 65, no. 3 (February 1, 1990): 439–45. https://doi.org/10.1002/1097-0142(19900201)65:3<439::aid-cncr2820650311>3.0.co;2-w.
       Full Text  Link to Item
    • George, S., A. McBurney, and A. Cole. “Possible protein binding displacement interaction between glibenclamide and metolazone.” Eur J Clin Pharmacol 38, no. 1 (1990): 93–95. https://doi.org/10.1007/BF00314813.
       Full Text  Link to Item
    • Moul, J. W., J. E. Robertson, S. L. George, D. F. Paulson, and P. J. Walther. “Complications of therapy for testicular cancer.” J Urol 142, no. 6 (December 1989): 1491–96. https://doi.org/10.1016/s0022-5347(17)39135-8.
       Full Text  Link to Item
    • Pui, C. H., F. G. Behm, S. C. Raimondi, R. K. Dodge, S. L. George, G. K. Rivera, J. Mirro, D. K. Kalwinsky, G. V. Dahl, and S. B. Murphy. “Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia.” N Engl J Med 321, no. 3 (July 20, 1989): 136–42. https://doi.org/10.1056/NEJM198907203210302.
       Full Text  Link to Item
    • George, S. L. “Identification and assessment of prognostic factors.” Semin Oncol 15, no. 5 (October 1988): 462–71.
       Link to Item
    • Shenep, J. L., D. K. Kalwinsky, P. R. Hutson, S. L. George, R. K. Dodge, K. R. Blankenship, and D. Thornton. “Efficacy of oral sucralfate suspension in prevention and treatment of chemotherapy-induced mucositis.” J Pediatr 113, no. 4 (October 1988): 758–63. https://doi.org/10.1016/s0022-3476(88)80397-4.
       Full Text  Link to Item
    • Plowman, P. N., O. J. Gilmore, and S. George. “Tamoxifen versus surgery in elderly patients with breast cancer.” Lancet 1, no. 8590 (April 16, 1988): 891–92. https://doi.org/10.1016/s0140-6736(88)91648-0.
       Full Text  Link to Item
    • Pratt, C. B., S. L. George, A. A. Green, L. A. Fields, and R. K. Dodge. “Carcinomas in children. Clinical and demographic characteristics.” Cancer 61, no. 5 (March 1, 1988): 1046–50. https://doi.org/10.1002/1097-0142(19880301)61:5<1046::aid-cncr2820610532>3.0.co;2-y.
       Full Text  Link to Item
    • Horowitz, M. E., E. Etcubanas, M. L. Christensen, J. A. Houghton, S. L. George, A. A. Green, and P. J. Houghton. “Phase II testing of melphalan in children with newly diagnosed rhabdomyosarcoma: a model for anticancer drug development.” J Clin Oncol 6, no. 2 (February 1988): 308–14. https://doi.org/10.1200/JCO.1988.6.2.308.
       Full Text  Link to Item
    • Wang, W. C., S. L. George, and J. A. Wilimas. “Transcutaneous electrical nerve stimulation treatment of sickle cell pain crises.” Acta Haematol 80, no. 2 (1988): 99–102. https://doi.org/10.1159/000205612.
       Full Text  Link to Item
    • Pratt, C. B., S. L. George, D. O’Connor, and R. E. Hoffman. “Adolescent colorectal cancer and dioxin exposure.” Lancet 2, no. 8562 (October 3, 1987): 803. https://doi.org/10.1016/s0140-6736(87)92541-4.
       Full Text  Link to Item
    • Pui, C. H., D. L. Williams, S. C. Raimondi, G. K. Rivera, A. T. Look, R. K. Dodge, S. L. George, F. G. Behm, W. M. Crist, and S. B. Murphy. “Hypodiploidy is associated with a poor prognosis in childhood acute lymphoblastic leukemia.” Blood 70, no. 1 (July 1987): 247–53.
       Link to Item
    • Pui, C. H., R. K. Dodge, S. L. George, and A. A. Green. “Height at diagnosis of malignancies.” Arch Dis Child 62, no. 5 (May 1987): 495–99. https://doi.org/10.1136/adc.62.5.495.
       Full Text  Link to Item
    • George, S. L., F. A. Pitt, and M. Watts. “Impact of cuts in acute beds on services for patients.” Br Med J (Clin Res Ed) 294, no. 6577 (April 11, 1987): 969. https://doi.org/10.1136/bmj.294.6577.969-a.
       Full Text  Link to Item
    • Houghton, J. A., L. G. Williams, R. K. Dodge, S. L. George, B. J. Hazelton, and P. J. Houghton. “Relationship between binding affinity, retention and sensitivity of human rhabdomyosarcoma xenografts to Vinca alkaloids.” Biochem Pharmacol 36, no. 1 (January 1, 1987): 81–88. https://doi.org/10.1016/0006-2952(87)90384-4.
       Full Text  Link to Item
    • Evans, W. E., W. R. Crom, M. Abromowitch, R. Dodge, A. T. Look, W. P. Bowman, S. L. George, and C. H. Pui. “Clinical pharmacodynamics of high-dose methotrexate in acute lymphocytic leukemia. Identification of a relation between concentration and effect.” N Engl J Med 314, no. 8 (February 20, 1986): 471–77. https://doi.org/10.1056/NEJM198602203140803.
       Full Text  Link to Item
    • George, S., A. McBurney, and J. W. Ward. “The pharmacokinetics of timegadine and two of its metabolites after multiple oral dosing, and the effects of concomitant administration of ibuprofen.” Eur J Clin Pharmacol 29, no. 5 (1986): 581–86. https://doi.org/10.1007/BF00635896.
       Full Text  Link to Item
    • Rivera, G. K., S. L. George, D. Williams, A. T. Look, M. Abromowitch, C. H. Pui, J. J. Ochs, G. V. Dahl, D. K. Kalwinsky, and J. Mirro. “Early results of intensified remission induction chemotherapy for childhood acute lymphocytic leukemia.” Med Pediatr Oncol 14, no. 3 (1986): 177–81. https://doi.org/10.1002/mpo.2950140313.
       Full Text  Link to Item
    • Williams, D. L., S. Raimondi, G. Rivera, S. George, C. W. Berard, and S. B. Murphy. “Presence of clonal chromosome abnormalities in virtually all cases of acute lymphoblastic leukemia.” N Engl J Med 313, no. 10 (September 5, 1985): 640–41. https://doi.org/10.1056/nejm198509053131016.
       Full Text  Link to Item
    • George, S. L., J. J. Ochs, A. M. Mauer, and J. V. Simone. “The importance of an isolated central nervous system relapse in children with acute lymphoblastic leukemia.” J Clin Oncol 3, no. 6 (June 1985): 776–81. https://doi.org/10.1200/JCO.1985.3.6.776.
       Full Text  Link to Item
    • George, S., P. Narasimhan, M. K. Banerjee, and S. A. Basha. “Nail patella syndrome.” J Assoc Physicians India 33, no. 4 (April 1985): 304–6.
       Link to Item
    • Chen, C. H., and S. L. George. “The bootstrap and identification of prognostic factors via Cox's proportional hazards regression model.” Stat Med 4, no. 1 (January 1985): 39–46. https://doi.org/10.1002/sim.4780040107.
       Full Text  Link to Item
    • George, S. L. “Statistics in medical journals: a survey of current policies and proposals for editors.” Med Pediatr Oncol 13, no. 2 (1985): 109–12. https://doi.org/10.1002/mpo.2950130215.
       Full Text  Link to Item
    • Kalwinsky, D. K., G. Rivera, G. V. Dahl, P. Roberson, S. George, S. B. Murphy, and J. V. Simone. “Variation by race in presenting clinical and biologic features of childhood acute lymphoblastic leukaemia: implications for treatment outcome.” Leuk Res 9, no. 6 (1985): 817–23. https://doi.org/10.1016/0145-2126(85)90300-5.
       Full Text  Link to Item
    • George, S., A. McBurney, and J. Ward. “The protein binding of timegadine determined by equilibrium dialysis.” Br J Clin Pharmacol 18, no. 5 (November 1984): 785–90. https://doi.org/10.1111/j.1365-2125.1984.tb02543.x.
       Full Text  Link to Item
    • Hazelton, B. J., P. M. Torrance, S. L. George, and P. J. Houghton. “Cloning efficiency of cultured human tumor cell lines measured with the use of a Coulter particle counter.” J Natl Cancer Inst 73, no. 3 (September 1984): 555–63.
       Link to Item
    • Pui, C. H., R. J. Aur, W. P. Bowman, G. V. Dahl, R. K. Dodge, S. L. George, J. Ochs, D. K. Kalwinsky, M. Abromowitch, and H. O. Hustu. “Failure of late intensification therapy to improve a poor result in childhood lymphoblastic leukemia.” Cancer Res 44, no. 8 (August 1984): 3593–98.
       Link to Item
    • McBurney, A., and S. George. “High-performance liquid chromatography of haloperidol in serum at the concentrations achieved during chronic therapy.” J Chromatogr 308 (June 8, 1984): 387–92. https://doi.org/10.1016/s0021-9673(01)87573-7.
       Full Text  Link to Item
    • Sackey, K., V. Odone, S. L. George, and S. B. Murphy. “Poland's syndrome associated with childhood non-Hodgkin's lymphoma.” Am J Dis Child 138, no. 6 (June 1984): 600–601.
       Link to Item
    • Dickinson, A. M., S. George, and S. J. Proctor. “T cell subpopulations in CLL: methods of T cell enrichment artificially alter proportions of OKT4 and OKT8 positive cells.” Clin Exp Immunol 54, no. 2 (November 1983): 525–31.
       Link to Item
    • Rivera, G., S. L. George, W. P. Bowman, D. Kalwinsky, J. Ochs, G. V. Dahl, H. O. Hustu, and J. V. Simone. “Second central nervous system prophylaxis in children with acute lymphoblastic leukemia who relapse after elective cessation of therapy.” J Clin Oncol 1, no. 8 (August 1983): 471–76. https://doi.org/10.1200/JCO.1983.1.8.471.
       Full Text  Link to Item
    • George, S. L., A. Whitton, and P. N. Plowman. “Hair regrowth after cancer therapy.” Hum Toxicol 2, no. 3 (July 1983): 465–72. https://doi.org/10.1177/096032718300200302.
       Full Text  Link to Item
    • George, S., K. Dauwe, A. McBurney, and J. Ward. “The influence of food intake on the bioavailability of timegadine, a novel non-steroidal anti-inflammatory drug.” Br J Clin Pharmacol 15, no. 4 (April 1983): 495–98. https://doi.org/10.1111/j.1365-2125.1983.tb01537.x.
       Full Text  Link to Item
    • Sanyal, S. K., R. C. Tierney, P. S. Rao, S. E. Pitner, S. L. George, and D. R. Givins. “Systolic time interval characteristics in children with Duchenne's progressive muscular dystrophy.” Pediatrics 70, no. 6 (December 1982): 958–64.
       Link to Item
    • Dahl, G. V., D. K. Kalwinsky, S. Murphy, A. T. Look, S. Amadori, M. Kumar, R. Novak, et al. “Cytokinetically based induction chemotherapy and splenectomy for childhood acute nonlymphocytic leukemia.” Blood 60, no. 4 (October 1982): 856–63.
       Link to Item
    • Odone, V., L. Chang, J. Caces, S. L. George, and C. B. Pratt. “The natural history of colorectal carcinoma in adolescents.” Cancer 49, no. 8 (April 15, 1982): 1716–20. https://doi.org/10.1002/1097-0142(19820415)49:8<1716::aid-cncr2820490831>3.0.co;2-m.
       Full Text  Link to Item
    • George, S. L. “Some historical perspectives on clinical therapeutic trials.” Cancer Bulletin 34, no. 3 (January 1, 1982): 113–16.
    • Murphy, S. B., G. V. Dahl, S. L. George, J. Karas, A. T. Look, J. V. Simone, and A. M. Mauer. “Determination of the significance of in vitro blast cell [3H]thymidine labelling indices obtained initially and serially during induction therapy of acute non-lymphocytic leukemia.” Leuk Res 6, no. 5 (1982): 639–48. https://doi.org/10.1016/0145-2126(82)90079-0.
       Full Text  Link to Item
    • Pratt, C. B., H. O. Hustu, A. P. Kumar, W. W. Johnson, J. L. Ransom, C. B. Howarth, and S. L. George. “Treatment of childhood rhabdomyosarcoma at St. Jude Children's Research Hospital, 1962--78.” Natl Cancer Inst Monogr, no. 56 (April 1981): 93–101.
       Link to Item
    • George, S. L. “Sequential clinical trials in cancer research.” Cancer Treat Rep 64, no. 2–3 (February 1980): 393–97.
       Link to Item
    • Komp, D. M., A. El Mahdi, K. A. Starling, J. Easley, T. J. Vietti, D. H. Berry, and S. L. George. “Quality of survival in histiocytosis X: a Southwest Oncology Group study.” Med Pediatr Oncol 8, no. 1 (1980): 35–40. https://doi.org/10.1002/mpo.2950080106.
       Full Text  Link to Item
    • Doering, E. J., R. Nitschke, M. E. Haggard, V. J. Land, S. K. Morgan, K. Starling, T. Williams, and S. George. “Phase II study demonstrating failure of both a five-drug continuous-therapy regimen and a two-drug pulse-therapy regimen in the treatment of metastatic neuroblastoma: Southwest Oncology Group Study 822.” Cancer Treat Rep 63, no. 8 (August 1979): 1383–84.
       Link to Item
    • Raghow, R., D. W. Kingsbury, A. Portner, and S. George. “Topography of a flexible ribonucleoprotein helix: protein-protein contacts in Sendai virus nucleocapsids.” J Virol 30, no. 3 (June 1979): 701–10. https://doi.org/10.1128/JVI.30.3.701-710.1979.
       Full Text  Link to Item
    • Rivera, G., R. J. Aur, G. V. Dahl, C. B. Pratt, H. O. Hustu, S. L. George, and A. M. Mauer. “Second cessation of therapy in childhood lymphocytic leukemia.” Blood 53, no. 6 (June 1979): 1114–20.
       Link to Item
    • George, S. L., R. J. Aur, A. M. Mauer, and J. V. Simone. “A reappraisal of the results of stopping therapy in childhood leukemia.” N Engl J Med 300, no. 6 (February 8, 1979): 269–73. https://doi.org/10.1056/NEJM197902083000601.
       Full Text  Link to Item
    • George, S. L., and E. A. Gehan. “Methods for measurement of body surface area.” J Pediatr 94, no. 2 (February 1979): 342–43. https://doi.org/10.1016/s0022-3476(79)80870-7.
       Full Text  Link to Item
    • George, S. L., D. J. Fernbach, and E. T. Lee. “Early deaths in newly diagnosed cases of pediatric acute leukemia: a Southwest Oncology Group Study.” Cancer 42, no. 2 (August 1978): 781–86. https://doi.org/10.1002/1097-0142(197808)42:2<781::aid-cncr2820420250>3.0.co;2-p.
       Full Text  Link to Item
    • George, S. L. “Design and evaluation of leukaemia trials.” Clin Haematol 7, no. 2 (June 1978): 227–43. https://doi.org/10.1016/s0308-2261(78)80003-4.
       Full Text  Link to Item
    • George, S. L., and B. Hoogstraten. “Prognostic factors in the initial response to therapy by patients with advanced breast cancer.” J Natl Cancer Inst 60, no. 4 (April 1978): 731–36. https://doi.org/10.1093/jnci/60.4.731.
       Full Text  Link to Item
    • Pratt, C. B., G. Rivera, E. Shanks, A. P. Kumar, A. A. Green, and S. George. “Combination chemotherapy for osteosarcoma.” Cancer Treat Rep 62, no. 2 (February 1978): 251–57.
       Link to Item
    • Hughes, W. T., S. Kuhn, S. Chaudhary, S. Feldman, M. Verzosa, R. J. Aur, C. Pratt, and S. L. George. “Successful chemoprophylaxis for Pneumocystis carinii pneumonitis.” N Engl J Med 297, no. 26 (December 29, 1977): 1419–26. https://doi.org/10.1056/NEJM197712292972602.
       Full Text  Link to Item
    • Lane, D. M., S. L. George, D. Komp, D. Lonsdale, J. Pullen, A. Ragab, and K. A. Starling. “Effects of continuous or discontinuous maintenance therapy on subsequent remission maintenance in childhood leukemia.” Cancer 40, no. 5 (November 1977): 2005–9. https://doi.org/10.1002/1097-0142(197711)40:5<2005::aid-cncr2820400503>3.0.co;2-r.
       Full Text  Link to Item
    • Dow, L. W., L. Borella, L. Sen, R. J. Aur, S. L. George, A. M. Mauer, and J. V. Simone. “Initial prognostic factors and lymphoblast-erythrocyte rosette formation in 109 children with acute lymphoblastic leukemia.” Blood 50, no. 4 (October 1977): 671–82.
       Link to Item
    • Murphy, S. B., R. J. Aur, J. V. Simone, S. George, and A. M. Mauer. “Pretreatment cytokinetic studies in 94 children with acute leukemia. Relationship to other variables at diagnosis and to outcome of standard treatment.” Blood 49, no. 5 (May 1977): 683–91.
       Link to Item
    • Hart, J. S., S. L. George, E. Frei, G. P. Bodey, R. C. Nickerson, and E. J. Freireich. “Prognotic significance of pretreatment proliferative activity in adult acute leukemia.” Cancer 39, no. 4 (April 1977): 1603–17. https://doi.org/10.1002/1097-0142(197704)39:4<1603::aid-cncr2820390435>3.0.co;2-8.
       Full Text  Link to Item
    • Komp, D. M., T. J. Vietti, D. H. Berry, K. A. Starling, M. E. Haggard, and S. L. George. “Combination chemotherapy in histiocytosis X.” Med Pediatr Oncol 3, no. 3 (1977): 267–73. https://doi.org/10.1002/mpo.2950030308.
       Full Text  Link to Item
    • Hoogstraten, B., S. L. George, B. Samal, S. E. Rivkin, J. J. Costanzi, J. D. Bonnet, T. Thigpen, and H. Braine. “Combination chemotherapy and adriamycin in patients with advanced breast cancer. A Southwest Oncology Group study.” Cancer 38, no. 1 (July 1976): 13–20. https://doi.org/10.1002/1097-0142(197607)38:1<13::aid-cncr2820380104>3.0.co;2-5.
       Full Text  Link to Item
    • George, S. L. “The data center of the European Organization for Research on Treatment of Cancer.” Eur J Cancer 12, no. 3 (March 1976): 245–46. https://doi.org/10.1016/0014-2964(76)90250-4.
       Full Text  Link to Item
    • Komp, D. M., S. L. George, J. Falletta, V. J. Land, K. A. Starling, G. B. Humphrey, and J. Lowman. “Cyclophosphamide-asparaginase- vincristine-prednisone induction therapy in childhood acute lymphocytic and nonlymphocytic leukemia.” Cancer 37, no. 3 (March 1976): 1243–47. https://doi.org/10.1002/1097-0142(197603)37:3<1243::aid-cncr2820370303>3.0.co;2-6.
       Full Text  Link to Item
    • Sutow, W. W., S. George, J. T. Lowman, K. A. Starling, G. B. Humphrey, M. E. Haggard, and T. J. Vietti. “Evaluation of dose and schedule of L-asparaginase in multidrug therapy of childhood leukemia.” Med Pediatr Oncol 2, no. 4 (1976): 387–95. https://doi.org/10.1002/mpo.2950020405.
       Full Text  Link to Item
    • Cangir, A., S. George, and M. Sullivan. “Unfavorable prognosis of acute leukemia in infancy.” Cancer 36, no. 6 (December 1975): 1973–78. https://doi.org/10.1002/cncr.2820360907.
       Full Text  Link to Item
    • Lanzotti, V. J., E. M. Copeland, S. L. George, S. J. Dudrick, and M. L. Samuels. “Cancer chemotherapeutic response and intravenous hyperalimentation.” Cancer Chemother.Rep. 59, no. 2 (December 1, 1975): 437–39.
    • Fernbach, D. J., S. L. George, W. W. Sutow, A. H. Ragab, D. M. Lane, M. E. Haggard, and D. Lonsdale. “Long-term results of reinforcement therapy in children with acute leukemia.” Cancer 36, no. 5 (November 1975): 1552–59. https://doi.org/10.1002/1097-0142(197511)36:5<1552::aid-cncr2820360503>3.0.co;2-3.
       Full Text  Link to Item
    • Ragab, A. H., W. W. Sutow, D. M. Komp, K. A. Starling, G. M. Lyon, and S. George. “Adriamycin in the treatment of childhood solid tumors. A Southwest Oncology Group study.” Cancer 36, no. 5 (November 1975): 1567–76. https://doi.org/10.1002/1097-0142(197511)36:5<1567::aid-cncr2820360505>3.0.co;2-i.
       Full Text  Link to Item
    • Sutow, W. W., M. P. Sullivan, D. J. Fernbach, A. Cangir, and S. L. George. “Adjuvant chemotherapy in primary treatment of osteogenic sarcoma. A Southwest Oncology Group study.” Cancer 36, no. 5 (November 1975): 1598–1602. https://doi.org/10.1002/1097-0142(197511)36:5<1598::aid-cncr2820360511>3.0.co;2-n.
       Full Text  Link to Item
    • Ragab, A. H., W. W. Sutow, D. M. Komp, K. A. Starling, G. M. Lyon, and S. George. “Adriamycin in the treatment of childhood acute leukemia. A Southwest Oncology Group study.” Cancer 36, no. 4 (October 1975): 1223–26. https://doi.org/10.1002/1097-0142(197510)36:4<1223::aid-cncr2820360407>3.0.co;2-7.
       Full Text  Link to Item
    • Berry, D. H., J. Pullen, S. George, T. J. Vietti, M. P. Sullivan, and D. Fernbach. “Comparison of prednisolone, vincristine, methotrexate, and 6-mercaptopurine vs. vincristine and prednisone induction therapy in childhood acute leukemia.” Cancer 36, no. 1 (July 1975): 98–102. https://doi.org/10.1002/1097-0142(197507)36:1<98::aid-cncr2820360105>3.0.co;2-r.
       Full Text  Link to Item
    • Murphy, W. K., R. B. Livingston, V. G. Ruiz, F. G. Gercovich, S. L. George, J. S. Hart, and E. J. Freireich. “Serial labeling index determination as a predictor of response in human solid tumors.” Cancer Res 35, no. 6 (June 1975): 1438–44.
       Link to Item
    • Fernandez, C. H., W. W. Sutow, O. R. Merino, and S. L. George. “Childhood rhabdomyosarcoma. Analysis of coordinated therapy and results.” Am J Roentgenol Radium Ther Nucl Med 123, no. 3 (March 1975): 588–97. https://doi.org/10.2214/ajr.123.3.588.
       Full Text  Link to Item
    • Humphrey, B., D. J. Fernbach, A. A. Razek, W. J. Stuckey, D. Komp, and S. George. “Evaluation of daunorubicin (NSC-82151) and methotrexate (NSC-740) in combination as a remission maintenance regimen in the treatment of acute leukemia.” Cancer Chemother Rep 59, no. 2 Pt 1 (March 1975): 395–99.
       Link to Item
    • Lanzotti, V. J., E. M. Copeland, S. L. George, S. J. Dudrick, and M. L. Samuels. “Cancer chemotherapeutic response and intravenous hyperalimentaion.” Cancer Chemother Rep 59, no. 2 Pt 1 (March 1975): 437–39.
       Link to Item
    • Pierce, K. R., C. J. Fraser, J. H. Jardine, and S. L. George. “Concentration of various chemical constituents in the blood of normal cats.” Journal of the American Animal Hospital Association 11, no. 3 (January 1, 1975): 293–99.
    • Livingston, R. B., U. Ambus, S. L. George, E. J. Freireich, and J. S. Hart. “In vitro determination of thymidine-3H labeling index in human solid tumors.” Cancer Res 34, no. 6 (June 1974): 1376–80.
       Link to Item
    • Trujillo, J. M., A. Cork, J. S. Hart, S. L. George, and E. J. Freireich. “Clinical implications of aneuploid cytogenetic profiles in adult acute leukemia.” Cancer 33, no. 3 (March 1974): 824–34. https://doi.org/10.1002/1097-0142(197403)33:3<824::aid-cncr2820330330>3.0.co;2-k.
       Full Text  Link to Item
    • George, S. L., and M. M. Desu. “Planning the size and duration of a clinical trial studying the time to some critical event.” J Chronic Dis 27, no. 1 (February 1974): 15–24. https://doi.org/10.1016/0021-9681(74)90004-6.
       Full Text  Link to Item
    • George, S. L., and M. M. Desu. “Planning the size and duration of a clinical trial studying the time to some critical event.” Journal of Chronic Diseases 27, no. 1–2 (1974): 15–24.
    • Hoogstraten, B., and S. George. “Adriamycin and combination chemotherapy in breast cancer: A Southwest oncology group study.” Proceedings of the American Association for Cancer Research Vol. 15 (January 1, 1974).
    • Komp, D., S. George, and V. Land. “Response and toxicity in childhood leukemia when cyclophosphamide and L asparaginase are added to vincristine prednisone induction.” Proceedings of the American Association for Cancer Research Vol. 15 (January 1, 1974).
    • Lane, D. M., S. L. George, and D. Komp. “Continuous maintenance therapy following either continuous or discontinuous maintenance therapy in childhood leukemia.” Proceedings of the American Association for Cancer Research Vol. 15 (January 1, 1974).
    • George, S. L., D. J. Fernbach, T. J. Vietti, M. P. Sullivan, D. M. Lane, M. E. Haggard, D. H. Berry, D. Lonsdale, and D. Komp. “Factors influencing survival in pediatric acute leukemia. The SWCCSG experience, 1958-1970.” Cancer 32, no. 6 (December 1973): 1542–53. https://doi.org/10.1002/1097-0142(197312)32:6<1542::aid-cncr2820320634>3.0.co;2-d.
       Full Text  Link to Item
    • Hart, J. S., D. H. Ho, S. L. George, P. Salem, J. A. Gottlieb, and E. Frei. “Cytokinetic and molecular pharmacology studies of arabinosylcytosine in metastatic melanoma.” Cancer Res 32, no. 12 (December 1972): 2711–16.
       Link to Item
    • Savage, R. D., P. G. Britton, S. George, D. O’Connor, and E. H. Hall. “A developmental investigation of intellectual functioning in the community aged.” J Genet Psychol 121, no. 1st Half (September 1972): 163–67. https://doi.org/10.1080/00221325.1972.10533139.
       Full Text  Link to Item
    • Savage, R. D., P. G. Britton, S. George, D. O’Connor, and E. H. Hall. “A developmental investigation of intellectual functioning in the community aged.” The Journal of Genetic Psychology ; Child Behavior, Animal Behavior, and Comparative Psychology 121, no. 1 st Half (1972): 163–67.
    • George, S. L. “Mortality reporting for childhood leukemia.” Pediatrics 48, no. 5 (November 1971): 846–47.
       Link to Item
    • Hart, J. S., J. M. Trujillo, E. J. Freireich, S. L. George, and E. Frei. “Cytogenetic studies and their clinical correlates in adults with acute leukemia.” Ann Intern Med 75, no. 3 (September 1971): 353–60. https://doi.org/10.7326/0003-4819-75-3-353.
       Full Text  Link to Item
    • George, S. L. “Evaluation of empirical Bayes estimators for small numbers of past samples.” Biometrika 58, no. 1 (April 1, 1971): 244. https://doi.org/10.1093/biomet/58.1.244.
       Full Text
    • Gehan, E. A., and S. L. George. “Estimation of human body surface area from height and weight.” Cancer Chemother Rep 54, no. 4 (August 1970): 225–35.
       Link to Item

  • Book Sections

    • George, S. L., X. Wang, and H. Pang. “Preface,” xv, 2016. https://doi.org/10.1201/9781315371566.
       Full Text
    • George, S. L., X. Wang, and H. Pang. “Preface,” xv, 2016. https://doi.org/10.1201/9781315371566.
       Full Text
    • George, Stephen, Xiaofei Wang, and Herbert Pang. “Endpoints for Cancer Clinical Trials.” In Cancer Clinical Trials: Current and Controversial Issues in Design and Analysis, edited by Stephen George, Xiaofei Wang, and Herbert Pang, 3–36. Chapman & Hall, 2016.
    • George, Stephen, Xiaofei Wang, and Herbert Pang. “Endpoints for Cancer Clinical Trials.” In Cancer Clinical Trials: Current and Controversial Issues in Design and Analysis, edited by Stephen George, Xiaofei Wang, and Herbert Pang, 3–36. Chapman & Hall, 2016.
    • Ren, Z., M. Davidian, S. L. George, R. M. Goldberg, F. A. Wright, A. A. Tsiatis, and M. R. Kosorok. “Research methods for clinical trials in personalized medicine: A systematic review.” In Lost in Translation: Barriers to Incentives for Translational Research in Medical Sciences, 659–84, 2014. https://doi.org/10.1142/9789814489072_0025.
       Full Text
    • George, Douglas J., and Douglas J. Wang. “Targeted Clinical Trials.” In Designs for Clinical Trials, edited by Douglas J. Harrington, 157–77. Springer, n.d.

  • Conference Papers

    • Wang, Ting, Xiaofei Wang, Haibo Zhou, Jianwen Cai, and Stephen L. George. “Biomarker stratified design enriched by auxiliary variables.” In Trials, Vol. 18. BIOMED CENTRAL LTD, 2017.
       Link to Item
    • Prosek, R., R. Willis, S. George, and D. Fulmer. “Update on the FAA UAS Program to the AUVSI Conference August 16, 2011.” In Auvsi Unmanned Systems North America Conference 2011, 1:42–60, 2011.
    • George, S. “FAA UAS sense and avoid workshops.” In Auvsi Unmanned Systems North America Conference 2010, 3:1670–92, 2010.
    • George, S. L., T. J. Polascik, D. M. Albala, P. J. Walther, J. Moul, J. F. Madden, D. C. Snyder, et al. “Impact of flaxseed supplementation and dietary fat restriction on prostate cancer proliferation and other biomarkers: Results of a Phase II randomized controlled trial (RCT) using a presurgical model.” In Journal of Clinical Oncology, Vol. 25. AMER SOC CLINICAL ONCOLOGY, 2007.
       Link to Item
    • Joffe, S., D. P. Harrington, S. L. George, E. J. Emanuel, L. Budzinski, and J. C. Weeks. “Fulfillment of the uncertainty principle in cancer clinical trials.” In Journal of Clinical Oncology, 22:519S-519S, 2004.
       Link to Item
    • Jung, S. H., T. Lee, K. M. Kim, and S. L. George. “Admissible two-stage designs for phase II cancer clinical trials.” In Controlled Clinical Trials, 24:61S-61S, 2003.
       Link to Item
    • George, S. L., and AMER S. T. A. T. ASSOC. “Design of marker studies.” In American Statistical Association 1996 Proceedings of the Biometrics Section, 90–92, 1996.
       Link to Item
    • GEORGE, S. L. “Statistical assessment of the utility of tumor markers.” In American Statistical Association 1994 Proceedings of the Section on Epidemiology, 8–13. AMER STATISTICAL ASSOC, 1994.
       Link to Item

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.